Navigation Links
UVA Health System part of Armed Forces multi-million dollar effort to help soldiers
Date:4/17/2008

A procedure currently performed all over the world for cosmetic purposes might also improve wound healing and limb function for soldiers who are severely hurt and scarred during combat. Dr. Adam Katz, plastic surgeon and researcher at the University of Virginia Health System, will conduct research in this area under the Armed Forces Institute of Regenerative Medicine (AFIRM). White House officials will announce the formation of AFIRM, which has received more than $80 million for research, on Thursday, April 17 at 1:30 p.m. EST.

Katz, who is the only Virginia doctor to be a part of AFIRM, will study the use of fat grafting for wounds and severe burns to improve their healing and/or to minimize their associated scarring. In one envisioned study, burn patients who have received skin grafts will receive an autologous fat transplant, in which their own fat tissue will be harvested, cleaned, and finally re-injected beneath the skin-grafted area. Katz believes the skin grafts may heal better with the placement of fat grafts, reducing and/or remodeling scar formation and mitigating scar contractures (tightness) which can limit the motion of limbs.

Traditionally fat grafting has been used to fill wrinkles or augment lips and other similar structures. More recently, a growing a number of physicians have noticed that fat grafting seems to have beneficial effects on surrounding tissue. Even more, recent published literature suggests that injecting fat around a wound helps it to heal better, said Katz. My goal now is to systematically and rigorously examine the potential effects of fat grafting on wound healing and scarring using controlled, blinded prospective studies to see if an old procedure can be used in a new way.

Katzs research also has a second component. He will extract and concentrate stem cells from fat tissue and explore their use (with or without biocompatible scaffolds) to engineer new skin or soft tissue to replace damaged d
'/>"/>

Contact: Abena Foreman-Trice
abena@virginia.edu
434-243-2734
University of Virginia Health System
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... As the International Day ... Ships celebrates with the story of a young boy bo...ies onboard the Africa Mercy, a floating hospital ...ow and he can run and play with the other children...e downloaded at www.mercyshipsnewsroom.org , ...
(Date:12/2/2008)... Orion Health announces th... (SEARHC) of Juneau, Alaska, has selected the Rhap...nt electronic health record, radiology, pharmacy, ...each other. It also plans to extend connectivity t...Alaska immunization registry) and AKAIMS (an MIS a...
(Date:12/2/2008)...ARIS, Dec. 2 Motorola, I...plemented its T2 powerbroadband system to enable,...e healthcare provider,Generale de Sante to deliv...,Motorola solution provides an advanced IP broadba...delivered over the existing telephone line, elimin...
(Date:12/1/2008)...OUTH BEND, Ind., Dec. 2 Patient sa...ities are on the rise according to a new report,f...ent Pulse Report: Patient,Perspectives on America...acilities as a driver for improvement in patient s... than 2 million patients treated at more than,1,2...
Breaking Medicine News(10 mins):Health News:Mercy Ships Recognizes International Day of Disabled Persons 2Health News:Mercy Ships Recognizes International Day of Disabled Persons 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 2Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 3Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2
...es Inc. today announced that Mylan Pharmaceuticals.... Food and Drug Administration (FDA) for its Abbr... Hydrochloride Extended-release Tablets, 12.5 mg a...o receive final approval on June 29, 2007, concurr...
...report released today documents the explosive grow...t more than 200 million people are now protected b...nd public places. The report concludes that the mo...accelerating because a global treaty ratified by 1...
...Technologies, Inc. (NTI) announced today the prese...l trials of ancrod and updates on the clinical de...TM) (ancrod), for the treatment of acute ischaemic...ss in Glasgow, Scotland in the United Kingdom. Vip...
... the number two killer in our nation, Americans ar...n fact, according to a recent nationwide survey sp... the scientific community is winning the war again...arching new options to fight cancer, Abbott is ho...
Other Medicine News:Health News:Growth of Smoke-Free Air Laws Worldwide; More Than 200 Million Found "Fully Protected" 2Health News:Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke 2Health News:Americans Optimistic About the War on Cancer 2
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-Firs...CSF) announced today that it has received full app...FDA) for its U.S. pivotal trial to study the effec...nd associated therapy in the prevention of Contras...so approved PLC,s request to expand their investig...
(Date:11/25/2008)...ire-USNewswire/ -- Kleinert Kutz and University o...S. hand transplant on Messina, New York resident, ...al Hand Care Center on Monday, November 24. The i...leted shortly after 9 p.m. in a record nine hours....in/prnh/20081125/DC48555-a ) , (Photo: http:/...
(Date:11/25/2008)... 25 Proteolix, Inc., a,leader in ...s that target,protein degradation pathways in can... data from two ongoing Phase 2 clinical trials of ... at the upcoming 50th Annual Meeting of the,Ameri...he first in a new class,of specific proteasome in...
(Date:11/25/2008)...swire-FirstCall/ -- Pharmacyclics, Inc.,(Nasdaq: ...leted a Phase 1,clinical trial with PCI-27483, th...Factor VIIa inhibitor. The trial was conducted in ...afety and pharmacologic effect of,PCI-27483. A si...ear dose,response in the International Normalized...
Breaking Medicine Technology:PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 1Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 2Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 3Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 4Consumer Safety Alert on Fat Dissolving Injections 3086 1Consumer Safety Alert on Fat Dissolving Injections 3086 2Consumer Safety Alert on Fat Dissolving Injections 3086 3N V Perricone M D Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications 3083 1N V Perricone M D Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications 3083 2Anaptys Biosciences Appoints R Scott Greer to Board of Directors 1119 1Anaptys Biosciences Appoints R Scott Greer to Board of Directors 1119 2
...-May 10, 2007 - According to,The Waismann Method 2...respondents seeking treatment for opiate dependenc...icodin, OxyContin, Percocet,and Fentanyl were amon...mothers who reported a dependency said they suffer...egistered addiction,specialist for the Waismann Me...
...oping Therapies to Prevent,and Reverse Atheroscler...07 /PRNewswire/ -- KineMed, Inc.,a pathway-based ...today the first method for measuring the efflux of...athway known as reverse cholesterol,transport (RCT...,cholesterol can be removed from tissues and has t...
Other Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3
Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large.
Rasp with down cutting pattern.
Designed for proximal femoral elevation in total hip replacement or in other surgery with a similar need for bone manipulation.
Beuse Zygomatic Arch Awl with slightly curved tip.
Medicine Products: